• The new trend for antiseizure medication selection in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020 

  Aydın, Kürşad; Kılıç, Betül; Serdaroğlu, Esra; Gönüllü Polat, Burçin; İnce, T.; Esenülkü, Gülnur; Topçu, Yasemin; Serdaroğlu, Ayşe; Haspolat, Şenay; Tekgül, Hasan; Okuyaz, Çetin; Cansu, Ali (Wiley, 2022)

  ...

• An interim analysis of the Turkish myeloma registry among the patients who have received up to two lines of therapy 

  Sevindik, Ömür Gökmen; Özkurt, Zübeyde Nur; Boğa, Can; Kalayoğlu Beşışık, Sevgi; Yıldız, İpek; Gedük, Ayfer; Harmandali, Aybüke; Salihoğlu, Ayşe; Haydaroğlu Şahin, Handan; Sönmez, Mehmet; Vural, Filiz; Akay, Olga Meltem; Kurt Yüksel, Meltem; Maral, Senem; Ekinci, Ömer; Kırkızlar, Hakkı Onur; Tekinalp, Atakan; Demir, Nazlı; Merter, Mustafa; Saydam, Güray; Alacacıoğlu, İnci; Yeğin, Zeynep Arzu; Kaşar, Mutlu; Mastanzade, Metban; Özsan, Güner Hayri (American Society of Hematology, 2022)

  ...

• Histopathological evaluation of gastrointestinal stromal tumours 

  Bayramoğlu, Zeynep; Yılmaz Erözbek, Sıla; Kuzucular, Elif; Özden, Ferhat (Springer, 2022)

  ...

• Primary leiomyosarcoma of the stomach: A case report 

  Özden, Ferhat; Çakır, Aslı (Springer, 2022)

  ...

• Mismatch repair status and PDL-1 expression in gastric carcinoma 

  Bayramoğlu, Zeynep; Yılmaz Erözbek, Sıla; Kuzucular, Elif; Özden, Ferhat (Springer, 2022)

  ...

• Random rescreening 10% of negative cervicovaginal smears: Method for quality assurance 

  Özden, Ferhat (Springer, 2022)

  ...

• Case report of a primary renal vein leiomyosarcoma 

  Yılmaz Erözbek, Sıla; Çakır, Aslı; Dervişoğlu, Sergülen (Springer, 2022)

  ...

• Evaluation of mismatch repair status in colorectal carcinoma 

  Yılmaz Erözbek, Sıla; Bayramoğlu, Zeynep; Kuzucular, Elif; Özden, Ferhat (Springer, 2022)

  ...

• HER2 expression and mismatch repair status in endometrial clear cell carcinoma 

  Yılmaz Erözbek, Sıla; Bayramoğlu, Zeynep; Özdemir, İsa Aykut; Ülker, Volkan; Müezzinoğlu, Bahar (Springer, 2022)

  ...

• NTRK-rearranged spindle cell neoplasm: A case report 

  Yılmaz Erözbek, Sıla; Çakır, Aslı; Dervişoğlu, Sergülen (Springer, 2022)

  ...

• Recent outcome of liver transplantation for Budd Chiari syndrome - analysis of the european liver transplant registry (ELTR) and affiliated centres 

  Dongelmans, E.; Polak, Wojciech; Adam, R.; Karam, Vincent; Pirenne, Jacques; Acarlı, Koray; Hakeem, A.; Dhakshinamoorthy, Vignesh; Fedaruk, Dzmitry; Rummo, Oleg; Kılıç, Merve; Nordin, Arno; Fischer, L.; Parente, Annalisa; Mirza, Dimitra; Bennet, William; Tokat, Yaman; Faitot, F.; Antonelli, Barbara; Muiesan, Paola; Nadalin, Sivio; Berlakovich, Gabrielle; Patch, D.; Berrevoet, Frederik; Ribnikar, Mojca; Gerster, Thomas; Savier, E.; Gruttadauria, S.; Ericzon, B. G.; Cuervas-Mons, Valentin; Saborido, B. Perez; Croner, R.; Magini, G.; Rossi, R.; Popescu, I.; Razvan, Lazea; Schneeberger, S.; Blokzijl, H.; Llado, L.; Gomez Bravo, Miguel Angel; Duvoux, Christophe; Mezjlik, V.; Oniscu, G.; Pearson, K.; Dayangaç, Murat; Lucidi, Valerio; Detry, Olivier; Rotellar, F.; Murad, S. Darwish (Lippincott Williams and Wilkins, 2022)

  ...

• Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study 

  Artaç, Mehmet; Çubukçu, Erdem; Bozkurt, Oktay; Bilici, Ahmet; Çelik, S.; Özçelik, M.; Öven, B.; Şimşek, E.; Geredeli, C.; Karaca, M.; Cil, T.; Harputluoğlu, Hakan; Şendur, Mehmet Ali Nahit; Türk, H. Mehmet; Kefeli, Umut; Alacacıoğlu, Ahmet; Tural, D.; Sakin, A.; Karadurmuş, Nuri; Çevik, Duygu; Dane, Faysal; Gümüş, Mahmut (Elsevier, 2022)

  Background: Randomized clinical trials showed that maintenance chemotherapy plus biologics in patients with mCRC could increase the progression free survival (PFS) without any advantage for overall survival (OS). Our aim ...

• Three-dimensional imaging of cleared human liver tissues reveals extensive fibrosis heterogeneity in non-alcoholic fatty liver disease 

  Yiğit, Buket; Özgönül, Ekin; Yaman, Ömer; Ulukan, Burge; Çetin Taş, Yağmur; Morova, Berna; Aydın, Musa; Uysallı, Yiğit; Demirtaş, Elif; Erkan, Mert; Gürsoy Özdemir, Yasemin; Karahüseyinoğlu, Serçin; Yurdaydın, Cihan; Akyıldız, Murat; Sheth, Abhishek; Kırımoğlu, Hale; Dayangaç, Murat; Ferhanoğlu, Onur; Kiraz, Alper; Zeybel, Müjdat (Elsevier, 2022)

  Background and aims: Liver fibrosis is a dynamic process of fibrogenesis and fibrolysis traditionally evaluated by liver biopsy. Accurate assessment of hepatic fibrosis is vital for optimal biomarker and drug development ...

• Dystonic features with cerebellar syndrome: a rare case of spinocerebellar ataxia type 16 

  Değirmenci, Yıldız; Zırh, Ali (Wiley, 2022)

  ...

• Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data 

  Karadurmuş, Nuri; Yıldırım, Emre; Yalçın, Şuayib; Gümüş, Mahmut; Bilir, Cemil; Çubukçu, Erdem; Tanrıkulu Şimşek, Eda; Arslan, Çağatay; Dane, Faysal; Çelik, Sinemiş; Bilici, Ahmet; Şendur, Mehmet Ali Nahit; Öven, Başak Bala; Işıkdoğan, Abdurrahman; Türk, Hacı Mehmet; Karaca, Mustafa; Karabulut, Bülent; Özçelik, Melike; Çevik, Duygu; Kefeli, Umut (Lippincott Williams & Wilkins, 2022)

  Background: The contribution of metastasectomy to progression-free survival (PFS) and overall survival (OS) in patients (pts) with advanced stage colorectal cancer has been demonstrated in clinical trials. However, clinical ...

• Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice 

  Tural, Deniz; Arslan, Çağatay; Selçukbiricik, Fatih; Ölmez, Ömer Fatih; Erman, Mustafa; Ürün, Yüksel; Karadurmuş, Nuri; Akar, Emre; Kılıçkap, Saadettin (Lippincott Williams & Wilkins, 2022)

  Background: Anti-tumor activity and manageable safety profile of immune checkpoint blockade therapies (ICT) have been demonstrated in previous clinical trials in patients with metastatic urothelial carcinoma. To the best ...

• The effect of depth and control point number for MLC transmission and dosimetric leaf gap 

  Küçükmorkoç, Esra; Doyuran, Mine; Çağlar, Mustafa; Küçük, Nadir; Acar, Hilal; Altınok, Ayşe; Çağlar, Hale (Elsevier Ireland Ltd., 2015)

  Purpose/Objective: MLC transmision (MLCT) and dosimetric leaf gap (DLG) in Treatment Planning System (TPS) are important parameters for dose calculation and they provide accuracy of delivering IMRT plans. MLCT and DLG ...

• The analysis of different percentage depth dose curves used for commissioning in eclipse 

  Cebe, Mehmet; Acar, Hilal; Küçük, Nadir; Küçükmorkoç, Esra; Doyuran, Mine; Çağlar, Mustafa; Altınok, Ayşe; Yilidir, G.; Mabhouti, H.; Çağlar, Hale (Wiley, 2015)

  Purpose: Percentage Depth Doses (PDDs) used for balance fitting of the calculation model in Eclipse. The effect of PDD curves measured with two different detectors for the commissioning of Truebeam STx machine to the ...

• Evaluation of interfractional bladder doses for two different patient positioning methods in prostate cancer 

  Altınok, Ayşe; Acar, Hilal; Rzazade, Rashad; Küçük, Nadir; Küçükmorkoç, Esra; Doyuran, Mine; Mabhouti, H.; Çağlar, Hale Başak (Elsevier Ireland Ltd., 2015)

  Purpose/Objective: MR imaging following needle implantation in high dose rate brachytherapy (HDR BT) provide more anatomical details for improved definition of the prostate gland, organs at risk, and needles. The purpose ...

• Dosimetric comparison of dose distributions in episcleral plaque brachytherapy 

  Acar, Hilal; Ozbay, Imre (Elsevier İreland Ltd., 2015)

  Purpose/Objective: Brachytherapy of intraocular tumors with 125I eye plaques has become a successful treatment modality and a viable alternat ive to enucleation. Plaque Simulator (PS) is an eye plaque treatment planning ...

View more